C. Segessenmann

Integration of pharmacokinetics and pharmacodynamics of imipenem in a human-adapted mouse model

U. Flückiger, A. Gerber, C. Segessenmann, 1991, Antimicrobial Agents and Chemotherapy.

Once-daily versus thrice-daily administration of netilmicin in combination therapy ofPseudomonas aeruginosa infection in a man-adapted neutropenic animal model

U. Flückiger, S. Kozak, A. Gerber, 1989, European Journal of Clinical Microbiology and Infectious Diseases.

Postantibiotic effect of roxithromycin, erythromycin, and clindamycin against selected gram-positive bacteria and Haemophilus influenzae.

A. Gerber, C. Segessenmann, B. Kuenzi, 1987, The Journal of antimicrobial chemotherapy.

The impact of the pre-treatment interval on antimicrobial efficacy in a biological model.

S. Kozak, A. Gerber, C. Segessenmann, 1993, The Journal of antimicrobial chemotherapy.

Simulation of human pharmacokinetic profiles in mice, and impact on antimicrobial efficacy of netilmicin, ticarcillin and ceftazidime in the peritonitis-septicemia model.

A. Gerber, C. Segessenmann, B. Stalder, 1990, Scandinavian Journal of Infectious Diseases. Supplementum.